Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02561585Phase 2Completed
A Phase 2 trial of delgocitinib in alopecia areata, sponsored by LEO Pharma. Started Jan 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02561585.